))
[박피디 픽]성능 뛰어난 화이자 코로나 알약 바이오기업 요동
Archived series ("Inactive feed" status)
When?
This feed was archived on October 13, 2022 23:14 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 306669191 series 1519912
Content provided by 경제브리핑. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by 경제브리핑 or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
화이자 코로나 치료제 즉 먹는 알약의 효과가 89%라는데 머크 알약이 50%였으니 훨씬 뛰어난 약품임을 공표한 셈이라고. 당장 화이자 주가는 10%이상, 머크 주가는 10%가까이 각각 오르고 하락. 국내 바이오 대장주들도 일제히 하락. SK바사는 14% 넘게 급락. 먹는 코로나 알약은 과연 게임체인저가 될 수 있을까. 이 외에 #요소수, 소변·비료로도 만들 수 있다? #마약반입 많은데…"특송물류센터 세관 직원도 딴짓" #전국민 재난지원금 추가 지급 반대 60.1% 진실은? #화이자코로나알약 #머크코로나알약 #화이자주가 #머크주가 #셀트리온주가 #sk바이오사이언스주가 #경불진 #경제브리핑_불편한진실
…
continue reading
2703 episodes
Share
